Canandaigua National Bank & Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,131
| Closed | -$234K | – | 339 |
|
|
2024
Q2 | $234K | Sell |
1,131
-6
| -0.5% | -$1.24K | 0.03% | 285 |
|
|
2024
Q1 | $308K | Sell |
1,137
-20
| -2% | -$5.42K | 0.05% | 214 |
|
|
2023
Q4 | $274K | Sell |
1,157
-17
| -1% | -$4.02K | 0.04% | 219 |
|
|
2023
Q3 | $230K | Sell |
1,174
-35
| -3% | -$6.86K | 0.04% | 236 |
|
|
2023
Q2 | $254K | Sell |
1,209
-13
| -1% | -$2.73K | 0.04% | 228 |
|
|
2023
Q1 | $247K | Buy |
+1,222
| New | +$247K | 0.04% | 227 |
|
|
2020
Q1 | $250K | Sell |
1,980
-167
| -8% | -$21.1K | 0.05% | 209 |
|
|
2019
Q4 | $328K | Sell |
2,147
-50
| -2% | -$7.64K | 0.06% | 209 |
|
|
2019
Q3 | $291K | Sell |
2,197
-63
| -3% | -$8.35K | 0.05% | 218 |
|
|
2019
Q2 | $321K | Sell |
2,260
-95
| -4% | -$13.5K | 0.06% | 208 |
|
|
2019
Q1 | $342K | Sell |
2,355
-255
| -10% | -$37K | 0.07% | 195 |
|
|
2018
Q4 | $295K | Sell |
2,610
-435
| -14% | -$49.2K | 0.06% | 210 |
|
|
2018
Q3 | $410K | Sell |
3,045
-74
| -2% | -$9.96K | 0.07% | 187 |
|
|
2018
Q2 | $350K | Buy |
3,119
+23
| +0.7% | +$2.58K | 0.07% | 215 |
|
|
2018
Q1 | $330K | Buy |
+3,096
| New | +$330K | 0.04% | 275 |
|